Literature DB >> 3259588

Calcitonin gene-related peptide (CGRP) in the human spinal cord: a light and electron microscopic analysis.

P A Harmann1, K Chung, R P Briner, K N Westlund, S M Carlton.   

Abstract

The distribution of CGRP immunoreactivity in the cervical, thoracic, lumbar, and sacral levels of the human spinal cord was mapped at the light microscopic level with the aid of a rabbit-generated antiserum against human calcitonin gene-related peptide (CGRP). CGRP-positive fibers formed a dense plexus in lamina I, II, the reticulated region of lamina V, and the tract of Lissauer at all spinal cord levels. The distribution of fibers showed some variations dependent on the cord level analyzed. At the light microscopic level, intervaricose fiber diameters consistently measured 1.0 micron or less, and two types of CGRP varicosities were observed: a small (1 to 2 microns in diameter), relatively round profile and a larger, (3 to 4 microns in diameter) oval or oblong profile. At the electron microscopic level, immunostained varicosities contained a mixture of round clear vesicles and vesicles that contained dense cores. The CGRP immunoreaction product was often associated with vesicles containing dense cores. The reaction product was also seen associated with clear round vesicles or in the cytoplasmic matrix. Postsynaptic elements included dendritic spines, small and large diameter dendritic shafts and vesicle containing profiles. The presence of CGRP in the superficial dorsal horn of human spinal cord is highly suggestive of a role in primary afferent transmission as postulated in lower vertebrates. This study establishes the distribution of CGRP at four different spinal levels in human cord and will serve as a basis for future studies related to the pathologic conditions affecting sensory systems.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259588     DOI: 10.1002/cne.902690305

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  13 in total

1.  Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury.

Authors:  R Grill; K Murai; A Blesch; F H Gage; M H Tuszynski
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

2.  Colitis induces calcitonin gene-related peptide expression and Akt activation in rat primary afferent pathways.

Authors:  Li-Ya Qiao; John R Grider
Journal:  Exp Neurol       Date:  2009-05-05       Impact factor: 5.330

3.  Termination patterns of calcitonin gene-related peptide-immunoreactive nerve fibers in the dorsal horn of the human spinal cord.

Authors:  G Jakab; I Salamon; P Petrusz; M Réthelyi
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

4.  Diverse spinal commissural neuron populations revealed by fate mapping and molecular profiling using a novel Robo3Cre mouse.

Authors:  Alastair J Tulloch; Shaun Teo; Brigett V Carvajal; Marc Tessier-Lavigne; Alexander Jaworski
Journal:  J Comp Neurol       Date:  2019-06-14       Impact factor: 3.215

5.  Temperature dependency of basal and evoked release of amino acids and calcitonin gene-related peptide from rat dorsal spinal cord.

Authors:  D M Dirig; X Y Hua; T L Yaksh
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

6.  The immunocytochemical distribution of seven peptides in the spinal cord and dorsal root ganglia of horse and pig.

Authors:  A Merighi; S Kar; S J Gibson; S Ghidella; A Gobetto; S M Peirone; J M Polak
Journal:  Anat Embryol (Berl)       Date:  1990

7.  Calcitonin gene-related peptide immunoreactivity in spinal spheroids in motor neuron disease.

Authors:  T Kato; T Katagiri; A Hirano; T Kawanami; Y Shikama; K Kurita; H Sasaki; S Arai
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Localization of calcitonin gene-related peptide in the small intestine of various vertebrate species.

Authors:  R Ohtani; T Kaneko; L W Kline; T Labedz; Y Tang; P K Pang
Journal:  Cell Tissue Res       Date:  1989-10       Impact factor: 5.249

9.  Blockers of Wnt3a, Wnt10a, or β-Catenin Prevent Chemotherapy-Induced Neuropathic Pain In Vivo.

Authors:  Hee Kee Kim; Jingi Bae; Sung Ho Lee; Seon-Hee Hwang; Min-Sik Kim; Moon Jong Kim; Sohee Jun; Chris L Cervantes; Youn-Sang Jung; Seunghoon Back; Hangyeore Lee; Seung-Eun Lee; Patrick M Dougherty; Sang-Won Lee; Jae-Il Park; Salahadin Abdi
Journal:  Neurotherapeutics       Date:  2020-10-30       Impact factor: 7.620

10.  Nitric oxide-producing islet cells modulate the release of sensory neuropeptides in the rat substantia gelatinosa.

Authors:  P Aimar; L Pasti; G Carmignoto; A Merighi
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.